FDA Grants Approval for Deflazacort ANDA220709 by Carnegie
The FDA has granted approval for the ANDA220709 application for Deflazacort submitted by Carnegie.
Asset / Drug
Drug and asset intelligence for Carnegie with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.